We are live on ! Find out more
IART icon

Integra LifeSciences

277 hedge funds and large institutions have $5.16B invested in Integra LifeSciences in 2021 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 97 increasing their positions, 89 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 25

6% more funds holding

Funds holding: 261277 (+16)

9% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 89

0.49% more ownership

Funds ownership: 90.91%91.4% (+0.49%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

2% less capital invested

Capital invested by funds: $5.26B → $5.16B (-$102M)

92% less call options, than puts

Call options by funds: $913K | Put options by funds: $11.6M

Holders
277
Holders Change
+16
Holders Change %
+6.13%
% of All Funds
4.26%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
44
Increased
97
Reduced
89
Closed
25
Calls
$913K
Puts
$11.6M
Net Calls
-$10.7M
Net Calls Change
-$11.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Allspring Global Investments
76
Allspring Global Investments
North Carolina
$3.59M +$3.63M +53,642 New
TPSF
77
Texas Permanent School Fund
Texas
$3.52M -$87.3K -1,291 -2%
AB
78
Amalgamated Bank
New York
$3.49M -$59.7K -882 -2%
FNBOO
79
First National Bank of Omaha
Nebraska
$3.48M +$100K +1,484 +3%
Russell Investments Group
80
Russell Investments Group
United Kingdom
$3.43M
State of Tennessee, Department of Treasury
81
State of Tennessee, Department of Treasury
Tennessee
$3.27M -$2.71M -40,000 -45%
PI
82
PineBridge Investments
New York
$3.11M +$882K +13,033 +39%
ETC
83
Exchange Traded Concepts
Oklahoma
$3.06M -$113K -1,676 -4%
Citadel Advisors
84
Citadel Advisors
Florida
$3.02M +$2.5M +36,890 +449%
OCM
85
Olstein Capital Management
New York
$3.02M +$271K +4,000 +10%
GAM
86
Gotham Asset Management
New York
$2.99M +$1.29M +19,016 +74%
Prudential Financial
87
Prudential Financial
New Jersey
$2.86M +$172K +2,544 +7%
UBS Group
88
UBS Group
Switzerland
$2.78M +$541K +7,993 +24%
State of New Jersey Common Pension Fund D
89
State of New Jersey Common Pension Fund D
New Jersey
$2.73M +$216K +3,199 +9%
Bank of Nova Scotia
90
Bank of Nova Scotia
Ontario, Canada
$2.72M -$5.61M -82,901 -67%
Renaissance Technologies
91
Renaissance Technologies
New York
$2.67M +$2.07M +30,600 +330%
CSS
92
Cubist Systematic Strategies
Connecticut
$2.66M +$2.34M +34,651 +687%
YCM
93
Yousif Capital Management
Michigan
$2.53M +$2.55M +37,741 New
Thrivent Financial for Lutherans
94
Thrivent Financial for Lutherans
Minnesota
$2.53M -$32.9K -487 -1%
Canada Life
95
Canada Life
Manitoba, Canada
$2.48M +$179K +2,642 +8%
MIM
96
MetLife Investment Management
New Jersey
$2.36M +$24.1K +356 +1%
HW
97
Hancock Whitney
Mississippi
$2.33M -$32.7K -484 -1%
DTL
98
Dynamic Technology Lab
Singapore
$2.31M +$2.33M +34,500 New
Jane Street
99
Jane Street
New York
$2.27M +$1.52M +22,509 +197%
D.E. Shaw & Co
100
D.E. Shaw & Co
New York
$2.25M -$846K -12,500 -27%

IART Hedge Fund Activity: Q4 2021 in Review

277 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2021, worth a combined $5.16B — down 1.9% from $5.26B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new IART positions and 25 closed out — a net gain of 19 holders — while 97 added to existing stakes and 89 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $42.6M. The largest seller was ArrowMark Colorado Holdings, exiting entirely with an estimated $46.4M sold.

  • 277 institutional investors held Integra LifeSciences (IART) as of Q4 2021, up from 261 in Q3 2021.
  • Funds reported $5.16B of Integra LifeSciences stock for Q4 2021, down 1.9% quarter-over-quarter.
  • 44 funds opened new Integra LifeSciences positions in Q4 2021 and 25 closed out, a net change of +19 holders.
  • The largest Integra LifeSciences buyer in Q4 2021 was Goldman Sachs, an estimated $42.6M added.
  • The largest Integra LifeSciences seller in Q4 2021 was ArrowMark Colorado Holdings, an estimated $46.4M sold.

Based on aggregated 13F filings for Q4 2021.